Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Iron-quercetin nanocomplex preconditioning reprograms the mesenchymal stem cell secretome to drive angiogenic, fibroblast and immunoregulatory wound repair.

Kantapan J., Innuan P., Daranarong D., Roytrakul S., Jaikumkao K., Rolin G.

Laboratory Study on Diabetic Foot, Chronic Wound, Immune Modulation, published in Regen Biomater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Regen Biomater (2026)
Country
England
Reported sample size
—
Source database
PubMed
PMID
42437178
DOI
10.1093/rb/rbag132

Abstract (original English)

Chronic wounds remain a major clinical challenge characterized by impaired angiogenesis, persistent inflammation and dysfunctional stromal responses. Increasing evidence indicates that the therapeutic effects of mesenchymal stem cells (MSCs) are largely mediated by paracrine signaling, making MSC-derived secretomes promising cell-free regenerative therapies. However, conventional culture conditions do not fully harness MSC plasticity to enhance secretion of pro-regenerative factors. In this study, we investigated an iron-quercetin nanocomplex (IronQ) as a biocompatible preconditioning strategy to improve the therapeutic secretome of adipose-derived MSCs (ADSCs). IronQ priming preserved cell viability and phenotypic integrity while allowing efficient intracellular uptake. Transcriptomic analysis demonstrated coordinated ADSC reprogramming, with enrichment of pathways related to extracellular matrix organization, angiogenesis, immune regulation, iron homeostasis and tissue morphogenesis. Consistently, IronQ-preconditioned ADSC secretomes showed increased levels of key trophic and immunomodulatory factors, including VEGF-A, HGF, EGF, FGF-2, PDGF-AA, SDF-1α, G-CSF, CCL-2 and IL-10. Functionally, the conditioned secretome enhanced endothelial proliferation and tube formation, promoted fibroblast migration and activation, and induced macrophage polarization toward a reparative M2 phe

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research